Patient Derived Preclinical Models | MicrobiomeTrials← Back to trialsNCT05324553
Patient Derived Preclinical Models
RecruitingOBSERVATIONAL
Trial Details
Start: 2022-04-06Est. Completion: 2027-03-31
Enrollment target: 50 participants Locations- Mayo Clinic in Rochester, Rochester, Minnesota, United States
Other microbiome trials you might be interested in
Cancer
Patient reported outcomes (PRO) measure the health status directly reported by the patients, without external interpreta…
Nîmes, FranceEst. completion Dec 2028
Metastatic Non-Squamous Non-Small Cell Lung CancerAdult Solid Tumor
This is an exploratory, signal-finding, randomized, placebo-controlled, blinded, multi-center phase 2b trial of the anti…
Birmingham, United StatesEst. completion Oct 1, 2029
Phase 3
Recruiting
Unresectable Pleural Mesothelioma
This is a phase III, randomized, open-label, multicenter, global study to determine the efficacy and safety of Volrustom…
Santa Rosa, United StatesEst. completion Nov 16, 2028